文献速递冠心病外科

D-二聚体与冠状动脉旁路移植术后动脉及静脉桥血管闭塞相关

D-dimer is associated with arterial and venous coronary artery bypass graft occlusion.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-04-27

该前瞻性观察研究纳入330例择期初次冠状动脉旁路移植术患者,术前及出院时检测生物标志物,179例在术后18±2个月接受冠状动脉CT血管造影。共503条桥血管中46条(9.1%)闭塞,其中静脉桥29条(63%)、动脉桥17条(37%);179例患者中43例(24%)至少1条桥血管闭塞。较低基线D-二聚体水平及出院时总蛋白含量与随访期桥血管闭塞相关。

要点

  • 术后18个月随访中24%患者至少1条桥血管闭塞,静脉桥闭塞占63%。
  • 较低基线D-二聚体水平与整体桥血管闭塞独立相关(OR 2.58,95%CI 1.36-4.89,P=.00)。
  • D-二聚体分别与静脉桥(OR 2.67,95%CI 1.15-6.2,P=.022)及动脉桥(OR 2.5,95%CI 1.01-7.0,P=.05)闭塞相关。

核心结论

  • D-二聚体被识别为与动脉及静脉桥血管闭塞相关的生物标志物,可能有助于桥血管失败风险分层及新分子靶点发现。

研究设计与样本

  • 前瞻性观察研究,纳入330例择期初次冠状动脉旁路移植术患者,术前及出院时采血检测生物标志物。
  • 179例患者在术后18±2个月接受冠状动脉CT血管造影随访。

主要发现

  • 503条桥血管中46条(9.1%)闭塞,其中静脉桥29条(63%)、动脉桥17条(37%)。
  • 179例患者中43例(24%)至少1条桥血管闭塞。
  • 较低基线D-二聚体水平与整体桥血管闭塞相关(OR 2.58,95%CI 1.36-4.89,P=.00)。
  • 出院时总蛋白含量与整体桥血管闭塞相关(OR 1.09,95%CI 1.01-1.19,P=.028)。
  • 非左胸廓内动脉的动脉桥与整体桥血管闭塞相关(OR 2.92,95%CI 1.24-6.9,P=.078)。

关键数值与推荐

  • 静脉桥闭塞与D-二聚体相关(OR 2.67,95%CI 1.15-6.2,P=.022)。
  • 动脉桥闭塞与D-二聚体相关(OR 2.5,95%CI 1.01-7.0,P=.05)。
  • 静脉桥与整体桥血管闭塞可能相关(OR 1.51,95%CI 0.95-2.39,P=.078)。

临床怎么用

  • 可考虑检测基线D-二聚体水平以辅助识别桥血管闭塞风险较高的患者。
  • 对风险分层后的患者可加强术后随访与影像学评估。

局限性

  • 仅179例患者完成18个月冠状动脉CT血管造影随访,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In this observational prospective study, we assessed the role of clinical variables and circulating biomarkers in graft occlusion at 18 months to identify a signature for graft occlusion. METHODS: A total of 330 patients undergoing primary elective coronary artery bypass grafting were enrolled. Blood collection for biomarker assessment was performed before surgery and discharge. Patients were then scheduled to undergo coronary computed tomography angiography at 18 months follow-up, and 179 patients underwent coronary computed tomography angiography 18 ± 2 months postoperatively. RESULTS: There were 46 of 503 (9.1%) occluded grafts; of these, 29 (63%) were venous and 17 (37%) were arterial grafts; overall, 43 of 179 patients (24%) had at least 1 occluded graft. Logistic mixed effects model assessing independent factors associated with graft occlusion identified that lower D-dimer levels at baseline (odds ratio [OR], 2.58; 95% confidence interval [CI], 1.36-4.89; P = .00) and total protein content at discharge (OR, 1.09; 95% CI, 1.01-1.19; P = .028) were related to overall graft occlusion at follow-up, along with an arterial graft other than the left internal thoracic artery (OR, 2.92; 95% CI, 1.24-6.9; P = .078); moreover, a venous graft emerged was possibly associated with graft occlusion (OR, 1.51; 95% CI, 0.95-2.39; P = .078). By separately analyzing saphenous vein and arterial grafts, D-dimer levels (OR, 2.67; 95% CI, 1.15-6.2; P = .022 and OR, 2.5; 95% CI, 1.01-7.0; P = .05 for venous and arterial graft, respectively) were still associated with arterial and venous graft occlusion at follow-up. CONCLUSIONS: We identified D-dimer as a biomarker associated with arterial and venous grafts occlusion. This may help stratify patients at risk of graft failure and identify new molecular targets to prevent this complication.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Parolari A, Cavallotti L, Andreini D, et al. D-dimer is associated with arterial and venous coronary artery bypass graft occlusion. J Thorac Cardiovasc Surg. 2017. PMID: 28549694. doi:10.1016/j.jtcvs.2017.04.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。